# Pre-Submission Informational Package (No Meeting Requested)
## {device_description_short} — Product Code {product_code}

**Date:** {generated_date}
**Submission Type:** Informational Pre-Submission (No Meeting)
**Product Code:** {product_code} — {classification_device_name}
**Classification:** Class {device_class}, 21 CFR {regulation_number}
**Review Panel:** {review_panel}
**Generated:** {generated_date} | FDA Tools Plugin v5.25.0

---

## 1. Cover Letter

{cover_letter_date}

{review_division_name}
{office_name}
Center for Devices and Radiological Health
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993

**RE: Informational Pre-Submission Package — {device_trade_name}**

Dear Reviewer:

{applicant_name} is submitting this **informational Pre-Submission package** to provide FDA with advance notice of our planned 510(k) submission for our {device_description_short}. We believe this device is classified under product code **{product_code}** (21 CFR {regulation_number}, Class {device_class}).

**Purpose of this submission:**
We are providing this information to FDA for awareness purposes. We are **not requesting a meeting** or **formal FDA feedback** at this time.

**Background:**
We have completed our regulatory strategy development, predicate selection, and testing program design. We are submitting this package to:
- Inform FDA of our upcoming 510(k) submission timeline
- Provide advance notice of our device technology and indications
- Document our regulatory approach for FDA's awareness

We plan to submit our 510(k) premarket notification by **{target_510k_date}**.

If FDA has any preliminary concerns based on this informational package, we would appreciate notification so that we can address them before formal submission.

Sincerely,

{contact_first_name} {contact_last_name}
{contact_title}
{applicant_name}
{contact_email}
{contact_phone}

---

## 2. Device Description

### 2.1 Overview

{device_description}

{device_trade_name} is {device_type_category} intended for {primary_use_summary}.

**Key Features:**
- {feature_1}
- {feature_2}
- {feature_3}

### 2.2 Principle of Operation

{principle_of_operation}

[TODO: Company-specific — Brief description of how the device works]

### 2.3 Device Specifications

- **Dimensions:** {dimensions}
- **Weight:** {weight}
- **Materials (Patient Contact):** {materials_list}
- **Sterilization:** {sterilization_method}
- **Shelf Life:** {shelf_life_claim}

---

## 3. Indications for Use

**Device Trade Name:** {device_trade_name}

**Indications for Use:**

{intended_use}

**Prescription Use:** {rx_otc}

---

## 4. Regulatory Strategy

### 4.1 Proposed Pathway

We will pursue clearance via the **{proposed_pathway} 510(k)** pathway.

**Rationale:** {pathway_rationale}

### 4.2 Predicate Device

{predicate_analysis_table}

**Primary Predicate:**
- **K-Number:** {primary_predicate_k_number}
- **Device Name:** {primary_predicate_device_name}
- **Applicant:** {primary_predicate_applicant}
- **Decision Date:** {primary_predicate_decision_date}
- **Product Code:** {primary_predicate_product_code}

**Substantial Equivalence Summary:**

{se_rationale_summary}

[TODO: Company-specific — Summary of SE comparison showing same intended use and equivalent technological characteristics]

---

## 5. Testing Program

### 5.1 Biocompatibility Testing (if applicable)

{biocompatibility_testing_plan}

**Standards:** ISO 10993-1:2018

**Endpoints:** {biocompat_endpoints_list}

[TODO: Company-specific — Biocompatibility testing completed or in progress]

### 5.2 Performance Testing

{performance_testing_plan}

**Standards:** {performance_standards_list}

[TODO: Company-specific — Bench testing completed or in progress]

### 5.3 Sterilization Validation (if applicable)

{sterilization_testing_plan}

**Standards:** {sterilization_standards}

[TODO: Company-specific — Sterilization validation status]

### 5.4 Electrical Safety and EMC (if applicable)

{electrical_testing_plan}

**Standards:** IEC 60601-1, IEC 60601-1-2

[TODO: Company-specific — Electrical safety testing status if device is powered]

### 5.5 Software Verification and Validation (if applicable)

{software_testing_plan}

**Standards:** IEC 62304, IEC 62366-1

**Documentation Level:** {software_level}

[TODO: Company-specific — Software V&V status if device includes software]

### 5.6 Clinical Data

{clinical_data_summary}

[TODO: Company-specific — Clinical data status, or rationale for why clinical data is not needed]

---

## 6. Regulatory Background

### 6.1 FDA Guidance Reviewed

We have reviewed the following FDA guidance documents:

- *The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]* (2014)
- *Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1"* (2016)
- {additional_guidance_list}

### 6.2 Applicable Consensus Standards

**FDA-Recognized Consensus Standards:**

{standards_list}

[TODO: Company-specific — List from `/fda:standards {product_code}`]

### 6.3 Safety Intelligence

{safety_intelligence_summary}

**Predicate Safety History:**
- **MAUDE Adverse Events (Last 5 Years):** {maude_event_count} events for {primary_predicate_k_number}
- **Recalls:** {recall_count} recalls for product code {product_code} (Last 5 Years)

[TODO: Company-specific — Summary from `/fda:safety {product_code}`]

---

## 7. Submission Timeline

- **Testing completion target:** {testing_completion_date}
- **510(k) technical document finalization:** {technical_doc_date}
- **510(k) submission to FDA:** {target_510k_date}
- **Anticipated clearance:** {anticipated_clearance_date}

---

## 8. Contact Information

**Primary Regulatory Contact:**
- **Name:** {contact_first_name} {contact_last_name}
- **Title:** {contact_title}
- **Company:** {applicant_name}
- **Email:** {contact_email}
- **Phone:** {contact_phone}

**Alternate Contact (if applicable):**
- **Name:** {alternate_contact_name}
- **Email:** {alternate_contact_email}
- **Phone:** {alternate_contact_phone}

---

## 9. Supporting Materials

[TODO: Company-specific — List any supporting materials provided]

1. Device photographs
2. Predicate comparison table
3. Testing protocol summaries (high-level)
4. {additional_attachments}

---

## 10. Notes for FDA Reviewer

**No meeting or formal feedback requested at this time.**

This informational package is provided for FDA's awareness only. We understand that:
- FDA is not required to review this submission
- FDA is not required to provide feedback
- This submission does not guarantee acceptance of our regulatory approach
- FDA may contact us if there are preliminary concerns

If FDA has questions or concerns based on this information, please contact {contact_first_name} {contact_last_name} at {contact_email}.

---

## Disclaimer

> **Important:** This informational Pre-Submission package is AI-generated from public FDA data and project information. All content should be independently verified by qualified regulatory affairs professionals before submission to FDA. This document does not constitute regulatory advice.

---

**Document Control:**
- **Generated:** {generated_date}
- **Template:** info_only.md
- **Plugin Version:** 5.25.0
- **Project:** {project_name}
- **Meeting Type:** Informational Pre-Submission (No Meeting)
